Natera (NTRA) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)
Natera (NTRA) Net Income towards Common Stockholders Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 10.22% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 284.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.66% |
| Dec 31, 2025 | 32.60% |
| Sep 30, 2025 | 10.35% |
| Jun 30, 2025 | 11.40% |
| Mar 31, 2025 | 21.54% |
| Dec 31, 2024 | 27.41% |
| Sep 30, 2024 | 40.67% |
| Jun 30, 2024 | 31.40% |
| Mar 31, 2024 | -1.92% |
| Dec 31, 2023 | -0.71% |
| Sep 30, 2023 | -23.19% |
| Jun 30, 2023 | -22.94% |
| Mar 31, 2023 | -57.02% |
| Dec 31, 2022 | -59.43% |
| Sep 30, 2022 | -73.81% |
| Jun 30, 2022 | -64.82% |
| Mar 31, 2022 | -59.60% |
| Dec 31, 2021 | -64.04% |
| Sep 30, 2021 | -72.22% |
| Jun 30, 2021 | -50.81% |